908 Devices, which provides mass spectrometry devices for forensic and scientific research, raised $130 million by offering 6.5 million shares at $20, above the range of $18 to $19. The company had previously planned to offer 6.3 million shares at $15 to $17, before raising the range on Thursday. At pricing, 908 Devices raised 12% more in proceeds than anticipated and commands a fully diluted market value of $585 million.
908 Devices plans to list on the Nasdaq under the symbol MASS. Cowen, SVB Leerink, William Blair and Stifel acted as lead managers on the deal.
